Letermovir
1 clinical trials · Condition
| Record | Firm | Date |
|---|---|---|
| Letermovir Prophylaxis in Children With EBV-Positive T/NK-Cell Lymphoproliferative Disease and Refractory/Relapsed EBV-Associated Hemophagocytic Lymphohistiocytosis (NCT07488728) | Beijing Children's Hospital | 2025-10-01 |
Track Letermovir automatically
Every clearance here is in the API, with alerts when new ones post.